Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Escobedo-Aedo, PJ; Forjan-Gonzalez, A; Martinez, ASE; Ruiz-Ruano, VG; Sanchez-Alonso, S; Mata-Iturralde, L; Munoz-Lorenzo, L; Baca-Garcia, E; David, AS; Lopez-Morinigo, JD.

Investigating the Role of Insight, Decision-Making and Mentalizing in Functional Outcome in Schizophrenia: A Cross-Sectional Study

Behavioral Sciences. 2022; 12(2): Nº de citas: 8 [doi:10.3390/bs12020028]

Aggensteiner, PM; Holz, NE; Bottinger, BW; Baumeister, S; Hohmann, S; Werhahn, JE; Naaijen, J; Ilbegi, S; Glennon, JC; Hoekstra, PJ; Dietrich, A; Deters, RK; Saam, MC; Schulze, UME; Lythgoe, DJ; Sethi, A; Craig, MC; Mastroianni, M; Sagar-Ouriaghli, I; Santosh, PJ; Rosa, M; Bargallo, N; Castro-Fornieles, J; Arango, C; Penzol, MJ; Vidal, J; Franke, B; Zwiers, MP; Buitelaar, JK; Walitza, S; Banaschewski, T; Brandeis, D.

The effects of callous-unemotional traits and aggression subtypes on amygdala activity in response to negative faces

PSYCHOLOGICAL MEDICINE. 2022; 52(3): 476-484 Nº de citas: 31 [doi:10.1017/S0033291720002111]

Isomura, K; Sidorchuk, A; Sevilla-Cermeno, L; Akerstedt, T; Silverberg-Morse, M; Larsson, H; Mataix-Cols, D; de la Cruz, LF.

Insomnia in Tourette Syndrome and Chronic Tic Disorder

MOVEMENT DISORDERS. 2022; 37(2): 392-400 Nº de citas: 15 [doi:10.1002/mds.28842]

Estrade, A; de Pablo, GS; Zanotti, A; Wood, S; Fisher, HL; Fusar-Poli, P.

Public health primary prevention implemented by clinical high-risk services for psychosis

Translational Psychiatry. 2022; 12(1): Nº de citas: 21 [doi:10.1038/s41398-022-01805-4]

Aymerich, C; Pedruzo, B; Perez, JL; Laborda, M; Herrero, J; Blanco, J; Mancebo, G; Andres, L; Estevez, O; Fernandez, M; de Pablo, GS; Catalan, A; Gonzalez-Torres, MA.

COVID-19 pandemic effects on health worker's mental health: Systematic review and meta-analysis

EUROPEAN PSYCHIATRY. 2022; 65(1): Nº de citas: 216 [doi:10.1192/j.eurpsy.2022.1]

de Pablo, GS; Soardo, L; Cabras, A; Pereira, J; Kaur, S; Besana, F; Arienti, V; Coronelli, F; Il Shin, J; Solmi, M; Petros, N; Carvalho, AF; McGuire, P; Fusar-Poli, P.

Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis

Epidemiology and Psychiatric Sciences. 2022; 31: Nº de citas: 81 [doi:10.1017/S2045796021000639]

Andreu-Bernabeu Á; Díaz-Caneja CM; Costas J; De Hoyos L; Stella C; Gurriarán X; Alloza C; Fañanás L; Bobes J; González-Pinto A; Crespo-Facorro B; Martorell L; Vilella E; Muntané G; Nacher J; Molto MD; Aguilar EJ; Parellada M; Arango C; González-Peñas J.

Polygenic contribution to the relationship of loneliness and social isolation with schizophrenia.

Nature Communications. 2022; 13(1): 51-51 Nº de citas: 36 [doi:10.1038/s41467-021-27598-6]

Basurte-Villamor, I; Vega, P; Roncero, C; Martinez-Raga, J; Grau-Lopez, L; Aguilar, L; Torrens, M; Szerman, N.

A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

Neuropsychiatric Disease and Treatment. 2022; 18: 965-976 Nº de citas: 5 [doi:10.2147/NDT.S358782]

Jongs, N; Penninx, B; Arango, C; Ayuso-Mateos, JL; van der Wee, N; Winter-van Rossum, I; Saris, IMJ; van Echteld, A; Koops, S; Bilderbeck, AC; Raslescu, A; Dawson, GR; Sommer, B; Marston, H; Vorstman, JA; Eijkemans, MJC; Kas, MJ.

Effect of disease related biases on the subjective assessment of social functioning in Alzheimer's disease and schizophrenia patients

JOURNAL OF PSYCHIATRIC RESEARCH. 2022; 145: 302-308 Nº de citas: 21 [doi:10.1016/j.jpsychires.2020.11.013]

Bugarski-Kirola, D; Arango, C; Fava, M; Nasrallah, H; Liu, IY; Abbs, B; Stankovic, S.

Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe

Lancet Psychiatry. 2022; 9(1): 46-58 Nº de citas: 68 [doi:10.1016/S2215-0366(21)00386-2]

Correll, CU; Fusar-Poli, P; Leucht, S; Karow, A; Maric, N; Moreno, C; Nordentoft, M; Raballo, A.

Treatment Approaches for First Episode and Early-Phase Schizophrenia in Adolescents and Young Adults: A Delphi Consensus Report from Europe

Neuropsychiatric Disease and Treatment. 2022; 18: 201-219 Nº de citas: 8 [doi:10.2147/NDT.S345066]

Delgado, MEP; Perez, JJM; Garcia-Moreno, M; Lopez, CA; Cordon, RD; Gonzalez-Salvador, MT.

Descriptive Study of an Emotional Support Program for Relatives of Patients Hospitalized with COVID-19 in the Puerta de Hierro Hospital in Madrid

Revista Clinica Contemporanea. 2022; 13(1): [doi:10.5093/cc2022a4]

Amor, PJ; Echeburua, E; Camarillo, L; Ferre, F; Sarasua, B; Zubizarreta, I.

DEPENDENCIA EMOCIONAL Y MALTRATO EN MUJERES VICTIMAS DE VIOLENCIA CONTRA LA PAREJA

Behavioral Psychology-Psicologia Conductual. 2022; 30(1): 291-307 Nº de citas: 15 [doi:10.51668/bp.8322115s]

Saris, IMJ; Aghajani, M; Jongs, N; Reus, LM; van der Wee, NJA; Bilderbeck, AC; van Rossum, IW; Arango, C; de la Torre-Luque, A; Malik, A; Raslescu, A; Dawson, GR; Ayuso-Mateos, JL; Kas, MJ; Penninx, BWJH.

Cross-disorder and disorder-specific deficits in social functioning among schizophrenia and alzheimer's disease patients

PLoS One. 2022; 17(4): Nº de citas: 14 [doi:10.1371/journal.pone.0263769]

Al-Soufi, L; Martorell, L; Molto, MD; Gonzalez-Penas, J; Garcia-Portilla, MP; Arrojo, M; Rivero, O; Gutierrez-Zotes, A; Nacher, J; Muntane, G; Paz, E; Paramo, M; Bobes, J; Arango, C; Sanjuan, J; Vilella, E; Costas, J.

A polygenic approach to the association between smoking and schizophrenia

ADDICTION BIOLOGY. 2022; 27(1): Nº de citas: 5 [doi:10.1111/adb.13104]

Rosa-Justicia, M; Saam, MC; Flamarique, I; Borras, R; Naaijen, J; Dietrich, A; Hoekstra, PJ; Banaschewski, T; Aggensteiner, P; Craig, MC; Sethi, A; Santosh, P; Sagar-Ouriaghli, I; Arango, C; Penzol, MJ; Brandeis, D; Werhahn, JE; Glennon, JC; Franke, B; Zwiers, MP; Buitelaar, JK; Schulze, UME; Castro-Fornieles, J.

Subgrouping children and adolescents with disruptive behaviors: symptom profiles and the role of callous-unemotional traits

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2022; 31(1): 51-66 Nº de citas: 17 [doi:10.1007/s00787-020-01662-w]

Sonderby, IE; Ching, CRK; Thomopoulos, SI; van der Meer, D; Sun, DQ; Villalon-Reina, JE; Agartz, I; Amunts, K; Arango, C; Armstrong, NJ; Ayesa-Arriola, R; Bakker, G; Bassett, AS; Boomsma, DI; Bulow, R; Butcher, NJ; Calhoun, VD; Caspers, S; Chow, EWC; Cichon, S; Ciufolini, S; Craig, MC; Crespo-Facorro, B; Cunningham, AC; Dale, AM; Dazzan, P; de Zubicaray, GI; Djurovic, S; Doherty, JL; Donohoe, G; Draganski, B; Durdle, CA; Ehrlich, S; Emanuel, BS; Espeseth, T; Fisher, SE; Ge, T; Glahn, DC; Grabe, HJ; Gur, RE; Gutman, BA; Haavik, J; Haberg, AK; Hansen, LA; Hashimoto, R; Hibar, DP; Holmes, AJ; Hottenga, JJ; Pol, HHE; Jalbrzikowski, M; Knowles, EEM; Kushan, L; Linden, DEJ; Liu, JY; Lundervold, AJ; Martin-Brevet, S; Martinez, K; Mather, KA; Mathias, SR; McDonald-McGinn, DM; McRae, AF; Medland, SE; Moberget, T; Modenato, C; Sanchez, JM; Moreau, CA; Muhleisen, TW; Paus, T; Pausova, Z; Prieto, C; Ragothaman, A; Reinbold, CS; Marques, TR; Repetto, GM; Reymond, A; Roalf, DR; Rodriguez-Herreros, B; Rucker, JJ; Sachdev, PS; Schmitt, JE; Schofield, PR; Silva, AI; Stefansson, H; Stein, DJ; Tamnes, CK; Tordesillas-Gutierrez, D; Ulfarsson, MO; Vajdi, A; van 't Ent, D; van den Bree, MBM; Vassos, E; Vazquez-Bourgon, J; Vila-Rodriguez, F; Walters, GB; Wen, W; Westlye, LT; Wittfeld, K; Zackai, EH; Stefansson, K; Jacquemont, S; Thompson, PM; Bearden, CE; Andreassen, OA; CNV Working Grp; ENIGMA 22q11 2 Deletion.

Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs

HUMAN BRAIN MAPPING. 2022; 43(1): 300-328 Nº de citas: 52 [doi:10.1002/hbm.25354]

de Zwarte, SMC; Brouwer, RM; Agartz, I; Alda, M; Alonso-Lana, S; Bearden, CE; Bertolino, A; Bonvino, A; Bramon, E; Buimer, EEL; Cahn, W; Canales-Rodriguez, EJ; Cannon, DM; Cannon, TD; Caseras, X; Castro-Fornieles, J; Chen, Q; Chung, YH; de la Serna, E; Bonnin, CD; Demro, C; Di Giorgio, A; Doucet, GE; Eker, MC; Erk, S; Fatjo-Vilas, M; Fears, SC; Foley, SF; Frangou, S; Fullerton, JM; Glahn, DC; Goghari, VM; Goikolea, JM; Goldman, AL; Gonul, AS; Gruber, O; Hajek, T; Hawkins, EL; Heinz, A; Ongun, CH; Hillegers, MHJ; Houenou, J; Pol, HEH; Hultman, CM; Ingvar, M; Johansson, V; Jonsson, EG; Kane, F; Kempton, MJ; Koenis, MMG; Kopecek, M; Kramer, B; Lawrie, SM; Lenroot, RK; Marcelis, M; Mattay, VS; McDonald, C; Meyer-Lindenberg, A; Michielse, S; Mitchell, PB; Moreno, D; Murray, RM; Mwangi, B; Nabulsi, L; Newport, J; Olman, CA; van Os, J; Overs, BJ; Ozerdem, A; Pergola, G; Picchioni, MM; Piguet, C; Pomarol-Clotet, E; Radua, J; Ramsay, IS; Richter, A; Roberts, G; Salvador, R; Aydogan, AS; Sarro, S; Schofield, PR; Simsek, EM; Simsek, F; Soares, JC; Sponheim, SR; Sugranyes, G; Toulopoulou, T; Tronchin, G; Vieta, E; Walter, H; Weinberger, DR; Whalley, HC; Wu, MJ; Yalin, N; Andreassen, OA; Ching, CRK; Thomopoulos, SI; van Erp, TGM; Jahanshad, N; Thompson, PM; Kahn, RS; van Haren, NEM.

Intelligence, educational attainment, and brain structure in those at familial high-risk for schizophrenia or bipolar disorder

HUMAN BRAIN MAPPING. 2022; 43(1): 414-430 Nº de citas: 27 [doi:10.1002/hbm.25206]